Menu Menu

NRSNW    Neurosense Therapeutics Ltd    1875091    
Income Statement
Net Income ea0234951-6k_neurosense -6,261,000

Balance Sheet
Current Assets 1,619,000
Assets 1,841,000
Current Liabilities 3,508,000
Liabilities 3,544,000
Equity -1,703,000

Cash Flow Statement
Operating Cash Flow -5,750,000
Investing Cash Flow 1,000

Market Analysis
Market Cap 26,052,199
Price 0.21
BVPS 205.98
PS 14.52
FCF -5,749,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
Jul Aug Sep
9/30 -0.37
Oct Nov Dec

Find a discrepancy? The most accurate way to find company fundamental data is to view NRSNW documents filed with the SEC.


NRSNW Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas